Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:idelalisib
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
gptkb:L01EM01
|
| gptkbp:CASNumber |
870281-82-6
|
| gptkbp:chemicalFormula |
C22H18FN7O
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zedlig
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketingAuthorizationHolder |
gptkb:Gilead_Sciences
|
| gptkbp:mechanismOfAction |
PI3K delta inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
rash hepatotoxicity neutropenia inflammatory bowel disease pneumonitis |
| gptkbp:usedFor |
gptkb:small_lymphocytic_lymphoma
chronic lymphocytic leukemia follicular lymphoma |
| gptkbp:bfsParent |
gptkb:Rietschen
|
| gptkbp:bfsLayer |
7
|